- Home
- XENE vs VCYT Comparison
XENE vs VCYT Comparison
Compare XENE & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- VCYT
- Stock Information
- Founded
- XENE 1996
- VCYT 2006
- Country
- XENE Canada
- VCYT United States
- Employees
- XENE N/A
- VCYT N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- VCYT Medical Specialities
- Sector
- XENE Health Care
- VCYT Health Care
- Exchange
- XENE Nasdaq
- VCYT Nasdaq
- Market Cap
- XENE 2.9B
- VCYT 2.4B
- IPO Year
- XENE 2014
- VCYT 2013
- Fundamental
- Price
- XENE $36.70
- VCYT $31.83
- Analyst Decision
- XENE Strong Buy
- VCYT Buy
- Analyst Count
- XENE 11
- VCYT 9
- Target Price
- XENE $52.73
- VCYT $39.89
- AVG Volume (30 Days)
- XENE 636.6K
- VCYT 921.3K
- Earning Date
- XENE 11-11-2025
- VCYT 11-05-2025
- Dividend Yield
- XENE N/A
- VCYT N/A
- EPS Growth
- XENE N/A
- VCYT N/A
- EPS
- XENE N/A
- VCYT 0.34
- Revenue
- XENE $7,500,000.00
- VCYT $479,129,000.00
- Revenue This Year
- XENE N/A
- VCYT $14.19
- Revenue Next Year
- XENE $207.88
- VCYT $9.68
- P/E Ratio
- XENE N/A
- VCYT $95.21
- Revenue Growth
- XENE N/A
- VCYT 19.91
- 52 Week Low
- XENE $26.74
- VCYT $22.61
- 52 Week High
- XENE $46.00
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- XENE 49.37
- VCYT 58.59
- Support Level
- XENE $35.60
- VCYT $30.67
- Resistance Level
- XENE $39.55
- VCYT $32.34
- Average True Range (ATR)
- XENE 1.04
- VCYT 1.18
- MACD
- XENE -0.49
- VCYT -0.06
- Stochastic Oscillator
- XENE 25.94
- VCYT 73.71
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.